BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721
1321 results:

  • 1. [Detection of EWSR1 gene rearrangement by fluorescence in situ hybridization in bone and soft tissue tumors: clinical application evaluation and atypical signal analysis].
    Li L; Zhang M; Zhang TT; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):458-463. PubMed ID: 38678326
    [No Abstract]    [Full Text] [Related]  

  • 2. TSG-6 Inhibits the NF-κB Signaling Pathway and Promotes the Odontogenic Differentiation of Dental Pulp Stem Cells via CD44 in an Inflammatory Environment.
    Wang Y; Xie Y; Xue N; Xu H; Zhang D; Ji N; Chen Q
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540786
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. METTL3 Promotes Osteosarcoma Metastasis via an m6A-dependent Epigenetic Activity of CBX4.
    Huo XS; Lu D; Chen DG; Ye M; Wang XW; Shang FS
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):120. PubMed ID: 38538251
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Polyphyllin I enhances tumor necrosis factor-related apoptosis-inducing ligand-induced inhibition of human osteosarcoma cell growth downregulating the Wnt/β-catenin pathway.
    Junli C; Fulai Z; Xingyuan S; Xiaoping MA; Peng Z; Chujie Z; Binhao S; Wenchao GU; Yongjun W; Yanping Y
    J Tradit Chin Med; 2024 Apr; 44(2):251-259. PubMed ID: 38504531
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee.
    McLornan DP; Czerw T; Damaj G; Ethell M; Gurnari C; Hernández-Boluda JC; Polverelli N; Schwaab J; Sockel K; Raffaella G; Onida F; Sánchez-Ortega I; Battipaglia G; Elena C; Gotlib J; Reiter A; Rossignol J; Ustun C; Valent P; Yakoub-Agha I; Radia DH
    Leukemia; 2024 Apr; 38(4):699-711. PubMed ID: 38472477
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Extramedullary hematopoiesis in cancer.
    Barisas DAG; Choi K
    Exp Mol Med; 2024 Mar; 56(3):549-558. PubMed ID: 38443597
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Effect of Staphylococcal Nuclease and Tudor Domain Containing 1/SLC7A11 on the Occurrence and Development of Osteosarcoma by Inhibiting Ferroptosis].
    Wang ST; Xu SJ; Gui P; Li XN; Sui YH; Li ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):11-18. PubMed ID: 38433625
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
    Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
    Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. kit ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.
    Mühlenberg T; Falkenhorst J; Schulz T; Fletcher BS; Teuber A; Krzeciesa D; Klooster I; Lundberg M; Wilson L; Lategahn J; von Mehren M; Grunewald S; Tüns AI; Wardelmann E; Sicklick JK; Brahmi M; Serrano C; Schildhaus HU; Sievers S; Treckmann J; Heinrich MC; Raut CP; Ou WB; Marino-Enriquez A; George S; Rauh D; Fletcher JA; Bauer S
    J Clin Oncol; 2024 Apr; 42(12):1439-1449. PubMed ID: 38408285
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Oridonin-induced ferroptosis and apoptosis: a dual approach to suppress the growth of osteosarcoma cells.
    Zhang F; Hao Y; Yang N; Liu M; Luo Y; Zhang Y; Zhou J; Liu H; Li J
    BMC Cancer; 2024 Feb; 24(1):198. PubMed ID: 38347435
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia.
    Tettero JM; Heidinga ME; Mocking TR; Fransen G; Kelder A; Scholten WJ; Snel AN; Ngai LL; Bachas C; van de Loosdrecht AA; Ossenkoppele GJ; de Leeuw DC; Cloos J; Janssen JJWM
    Leukemia; 2024 Mar; 38(3):630-639. PubMed ID: 38272991
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
    Voissière A; Gomez-Roca C; Chabaud S; Rodriguez C; Nkodia A; Berthet J; Montane L; Bidaux AS; Treilleux I; Eberst L; Terret C; Korakis I; Garin G; Pérol D; Delord JP; Caux C; Dubois B; Ménétrier-Caux C; Bendriss-Vermare N; Cassier PA
    Sci Transl Med; 2024 Jan; 16(731):eadd1834. PubMed ID: 38266104
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mastocytosis in the skin in dogs: A multicentric case series.
    Wyatt EK; Affolter V; Borio S; Guillen A; Verganti S; Murphy S; Ballarini D; Banovic F; Schmidt V; Tanis JB
    Vet Comp Oncol; 2024 Mar; 22(1):136-148. PubMed ID: 38243867
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
    Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
    Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Circ_0000376 regulates miR-577/HK2/LDHA signaling pathway to promote the growth, invasion and glycolysis of osteosarcoma.
    Dai H; Yi G; Jiang D; Min Y; Li Z
    J Orthop Surg Res; 2024 Jan; 19(1):67. PubMed ID: 38218855
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma.
    Yang YT; Engleberg AI; Yuzbasiyan-Gurkan V
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201229
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.
    Heinrich MC; Jones RL; George S; Gelderblom H; Schöffski P; von Mehren M; Zalcberg JR; Kang YK; Razak AA; Trent J; Attia S; Le Cesne A; Siontis BL; Goldstein D; Boye K; Sanchez C; Steeghs N; Rutkowski P; Druta M; Serrano C; Somaiah N; Chi P; Reichmann W; Sprott K; Achour H; Sherman ML; Ruiz-Soto R; Blay JY; Bauer S
    Nat Med; 2024 Feb; 30(2):498-506. PubMed ID: 38182785
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via
    Wang L; Bai X; Zhang X; Wang X; Chen S; Wu S; Lin L
    Ann Clin Lab Sci; 2023 Nov; 53(6):920-930. PubMed ID: 38182151
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Acute mast cell leukemia without kit D816V mutation and lack of CD2 and CD25-a case report of rare entity.
    Zaremba-Pataj E; Patkowska E; Krzywdzińska A; Szumera-Ciećkiewicz A; Chlebowska-Tuz J
    J Hematop; 2023 Mar; 16(1):39-47. PubMed ID: 38175371
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Metastatic Undifferentiated Melanoma Mimicking a Primary bone Tumor: A Potential Diagnostic Pitfall.
    Wills A; Dibbern M; Frierson HF; Raghavan SS
    Am J Dermatopathol; 2024 Mar; 46(3):170-172. PubMed ID: 38170737
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 67.